{"id":"https://openalex.org/W2503527076","doi":"https://doi.org/10.1158/1538-7445.am2016-lb-177","title":"Abstract LB-177: PM01183 inactivates the EWS/FLI1 transcription factor by redistributing the protein within the nucleus","display_name":"Abstract LB-177: PM01183 inactivates the EWS/FLI1 transcription factor by redistributing the protein within the nucleus","publication_year":2016,"publication_date":"2016-07-15","ids":{"openalex":"https://openalex.org/W2503527076","doi":"https://doi.org/10.1158/1538-7445.am2016-lb-177","mag":"2503527076"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2016-lb-177","doi":"https://doi.org/10.1158/1538-7445.am2016-lb-177","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2016-lb-177","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103345401","display_name":"Matt L. Harlow","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matt Harlow","raw_affiliation_strings":["1Vanderbilt University, Nashville, TN;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Vanderbilt University, Nashville, TN;","institution_ids":["https://openalex.org/I200719446"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026842186","display_name":"Matthew K. Easton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1317189400","display_name":"Van Andel Institute","ror":"https://ror.org/00wm07d60","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1317189400"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matthew Easton","raw_affiliation_strings":["2Van Andel Research Institute, Grand Rapids, MI;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Van Andel Research Institute, Grand Rapids, MI;","institution_ids":["https://openalex.org/I1317189400"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074546909","display_name":"Maria Jose Guill\u00e9n Navarro","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210116403","display_name":"PharmaMar (Spain)","ror":"https://ror.org/02h694m69","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210116403"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Maria Jose Guill\u00e9n Navarro","raw_affiliation_strings":["3Pharmamar S.A., Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Pharmamar S.A., Madrid, Spain","institution_ids":["https://openalex.org/I4210116403"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Lisa Turner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1317189400","display_name":"Van Andel Institute","ror":"https://ror.org/00wm07d60","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1317189400"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lisa Turner","raw_affiliation_strings":["2Van Andel Research Institute, Grand Rapids, MI;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Van Andel Research Institute, Grand Rapids, MI;","institution_ids":["https://openalex.org/I1317189400"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062941900","display_name":"Galen H. Hostetter","orcid":"https://orcid.org/0000-0003-2616-6861","observed_orcids":["https://orcid.org/0000-0003-2616-6861"]},"institutions":[{"id":"https://openalex.org/I1317189400","display_name":"Van Andel Institute","ror":"https://ror.org/00wm07d60","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1317189400"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Galen Hostetter","raw_affiliation_strings":["2Van Andel Research Institute, Grand Rapids, MI;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Van Andel Research Institute, Grand Rapids, MI;","institution_ids":["https://openalex.org/I1317189400"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067025614","display_name":"Carlos Mar\u00eda Galmarini","orcid":"https://orcid.org/0000-0001-5494-6617","observed_orcids":["https://orcid.org/0000-0001-5494-6617","https://orcid.org/0000-0003-3361-217X"]},"institutions":[{"id":"https://openalex.org/I4210116403","display_name":"PharmaMar (Spain)","ror":"https://ror.org/02h694m69","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210116403"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Carlos Galmarini","raw_affiliation_strings":["3Pharmamar S.A., Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Pharmamar S.A., Madrid, Spain","institution_ids":["https://openalex.org/I4210116403"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072929714","display_name":"Pablo Avil\u00e9s","orcid":"https://orcid.org/0000-0003-0414-5365","observed_orcids":["https://orcid.org/0000-0003-0414-5365"]},"institutions":[{"id":"https://openalex.org/I4210116403","display_name":"PharmaMar (Spain)","ror":"https://ror.org/02h694m69","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210116403"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Pablo Aviles","raw_affiliation_strings":["3Pharmamar S.A., Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Pharmamar S.A., Madrid, Spain","institution_ids":["https://openalex.org/I4210116403"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5028721392","display_name":"Patrick Joseph Grohar","orcid":"https://orcid.org/0000-0002-1071-4563","observed_orcids":["https://orcid.org/0000-0002-1071-4563"]},"institutions":[{"id":"https://openalex.org/I1317189400","display_name":"Van Andel Institute","ror":"https://ror.org/00wm07d60","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1317189400"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Patrick Grohar","raw_affiliation_strings":["2Van Andel Research Institute, Grand Rapids, MI;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Van Andel Research Institute, Grand Rapids, MI;","institution_ids":["https://openalex.org/I1317189400"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"76","issue":"14_Supplement","first_page":"LB","last_page":"177"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10253","display_name":"Sarcoma Diagnosis and Treatment","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10253","display_name":"Sarcoma Diagnosis and Treatment","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12820","display_name":"Chromatin Remodeling and Cancer","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ews-fli1","display_name":"EWS-FLI1","score":0.8859999775886536},{"id":"https://openalex.org/keywords/ewing-sarcoma","display_name":"Ewing sarcoma","score":0.9950000047683716},{"id":"https://openalex.org/keywords/trabectedin","display_name":"trabectedin","score":0.8259999752044678},{"id":"https://openalex.org/keywords/nucleolar-translocation","display_name":"nucleolar translocation","score":0.6840000152587891},{"id":"https://openalex.org/keywords/transcription-factor-inactivation","display_name":"transcription factor inactivation","score":0.8209999799728394},{"id":"https://openalex.org/keywords/ewsr1","display_name":"EWSR1","score":0.6579999923706055},{"id":"https://openalex.org/keywords/small-molecule-drug-targets","display_name":"small molecule drug targets","score":0.42899999022483826},{"id":"https://openalex.org/keywords/xenograft-models","display_name":"xenograft models","score":0.6959999799728394},{"id":"https://openalex.org/keywords/keratinocytes","display_name":"keratinocytes","score":0.42899999022483826}],"concepts":[{"id":"https://openalex.org/C2780752271","wikidata":"https://www.wikidata.org/wiki/Q2637746","display_name":"Trabectedin","level":4,"score":0.898441731929779},{"id":"https://openalex.org/C2777937962","wikidata":"https://www.wikidata.org/wiki/Q17928801","display_name":"FLI1","level":4,"score":0.7215650677680969},{"id":"https://openalex.org/C2778256501","wikidata":"https://www.wikidata.org/wiki/Q223911","display_name":"Sarcoma","level":2,"score":0.6314016580581665},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5604093670845032},{"id":"https://openalex.org/C86339819","wikidata":"https://www.wikidata.org/wiki/Q407384","display_name":"Transcription factor","level":3,"score":0.525556206703186},{"id":"https://openalex.org/C2781225692","wikidata":"https://www.wikidata.org/wiki/Q6949365","display_name":"Myxoid liposarcoma","level":4,"score":0.46892812848091125},{"id":"https://openalex.org/C111829193","wikidata":"https://www.wikidata.org/wiki/Q1108970","display_name":"Fusion gene","level":3,"score":0.4351482391357422},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.414594441652298},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.393534779548645},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.3688029944896698},{"id":"https://openalex.org/C2778629024","wikidata":"https://www.wikidata.org/wiki/Q720020","display_name":"Soft tissue sarcoma","level":3,"score":0.30914247035980225},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.24809986352920532},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.18079662322998047},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.15422675013542175},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.12266489863395691},{"id":"https://openalex.org/C2779568860","wikidata":"https://www.wikidata.org/wiki/Q1827425","display_name":"Liposarcoma","level":3,"score":0.07653829455375671}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2016-lb-177","doi":"https://doi.org/10.1158/1538-7445.am2016-lb-177","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2016-lb-177","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.8560000061988831,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1526075325","https://openalex.org/W2529120334","https://openalex.org/W4393073053","https://openalex.org/W2741437104","https://openalex.org/W2142429004","https://openalex.org/W7154617097","https://openalex.org/W2912323391","https://openalex.org/W1536937502","https://openalex.org/W1974216923","https://openalex.org/W2562014388"],"abstract_inverted_index":{"Abstract":[0],"BACKGROUND:":[1],"Ewing":[2,29,86,122,229,236,312,392],"sarcoma":[3,10,30,87,123,230,237,313,393],"is":[4,92,127,252,370],"a":[5,23,163,173,255,263,304,331,342],"bone":[6],"and":[7,18,43,70,119,143,152,190,241,262,400],"soft":[8],"tissue":[9],"characterized":[11,306],"by":[12,254,325,340,431],"fusion":[13,338],"of":[14,38,85,121,132,150,171,197,205,211,235,257,267,271,285,303,311,334,344,391,398,441,446],"the":[15,35,63,81,105,117,130,135,148,169,195,209,215,248,268,275,286,289,301,316,320,345,350,364,373,388,427,433,436,442,447],"wild-type":[16,101,346,357],"EWSR1":[17,102,358],"FLI1":[19],"genes,":[20],"which":[21],"creates":[22],"constitutively":[24],"activated":[25],"transcription":[26,352,429],"factor,":[27],"EWS/FLI1.":[28,272],"cells":[31,88,124,238,394],"are":[32],"dependent":[33],"on":[34,182,214,277],"continued":[36],"activity":[37,69],"EWS/FLI1":[39,49,68,133,151,153,183,198,216,244,278,375,428],"to":[40,89,94,97,109,125,129,146,158,193,202,245,279,299,322,348,361,395],"block":[41],"differentiation":[42],"promote":[44],"proliferation.":[45],"For":[46],"these":[47,223,295],"reasons,":[48],"represents":[50],"an":[51,178,336],"ideal":[52],"drug":[53,287],"target.":[54],"With":[55],"this":[56,203,385,396],"in":[57,74,104,107,134,156,200,225,247,265,297,363],"mind,":[58],"we":[59,78,114,139,167,187,221],"have":[60],"shown":[61],"that":[62,80,116,356,384],"small":[64],"molecule":[65],"trabectedin":[66,90,126,161,378],"inhibits":[67],"synergizes":[71],"with":[72,177,239,315,377],"irinotecan":[73],"vivo.":[75],"In":[76,185],"addition,":[77,186],"showed":[79],"gene":[82,217,269],"expression":[83,266],"response":[84,108,118,157,201],"treatment":[91,213,310],"identical":[93],"keratinocytes":[95],"exposed":[96],"UV":[98,110,367],"light.":[99],"Interestingly,":[100,309],"accumulates":[103],"nucleolus":[106,365],"light":[111,368],"damage.":[112],"Therefore,":[113],"hypothesize":[115],"sensitivity":[120,390],"due":[128],"re-localization":[131],"nucleus.":[136,437],"METHODS:":[137],"Here,":[138],"utilize":[140],"confocal":[141],"microscopy":[142],"chromatin":[144],"immunoprecipitation":[145],"characterize":[147,168,330],"localization":[149],"deletion":[154],"mutants":[155],"trabectedin.":[159],"Because":[160],"has":[162,401],"narrow":[164],"therapeutic":[165],"index,":[166],"effect":[170,251,276],"PM01183,":[172],"second-generation":[174],"structural":[175],"analog":[176],"improved":[179],"pharmacokinetic":[180],"profile,":[181],"localization.":[184],"use":[188],"qPCR":[189],"western":[191],"blotting":[192],"determine":[194],"kinetics":[196],"inhibition":[199],"class":[204,397],"compounds.":[206],"W":[207],"demonstrate":[208,300,355],"effects":[210],"PM01183":[212,242,380,425],"signature":[218,270],"genome-wide.":[219],"Finally,":[220],"translate":[222],"findings":[224,296],"vivo":[226,298],"using":[227],"two":[228],"xenograft":[231],"models.":[232],"RESULTS:":[233],"Treatment":[234],"Trabectedin":[240],"causes":[243],"accumulate":[246,362],"nucleolus.":[249],"This":[250],"accompanied":[253],"loss":[256],"binding":[258],"at":[259],"target":[260],"sequences":[261],"reversal":[264],"We":[273,293,329,354,382],"found":[274],"be":[280,323],"sustained,":[281],"even":[282],"after":[283],"removal":[284],"from":[288],"cell":[290],"culture":[291],"medium.":[292],"extended":[294],"efficacy":[302],"previously":[305],"combination":[307,317],"therapy.":[308],"xenografts":[314],"therapy":[318],"caused":[319],"tumor":[321],"replaced":[324],"benign":[326],"adipocytes.":[327],"CONCLUSIONS:":[328],"novel":[332],"method":[333],"targeting":[335],"oncogenic":[337,351,374],"protein":[339,347,376,434],"leveraging":[341],"property":[343],"inactivate":[349],"factor.":[353],"protein's":[359],"propensity":[360],"upon":[366],"damage":[369],"maintained":[371],"within":[372,435],"or":[379],"treatment.":[381],"believe":[383],"accounts":[386],"for":[387,450],"heightened":[389],"compounds":[399],"numerous":[402],"clinical":[403],"implications.":[404],"Citation":[405],"Format:":[406],"Matt":[407],"Harlow,":[408],"Matthew":[409],"Easton,":[410],"Maria":[411],"Jose":[412],"Guill\u00e9n":[413],"Navarro,":[414],"Lisa":[415],"Turner,":[416],"Galen":[417],"Hostetter,":[418],"Carlos":[419],"Galmarini,":[420],"Pablo":[421],"Aviles,":[422],"Patrick":[423],"Grohar.":[424],"inactivates":[426],"factor":[430],"redistributing":[432],"[abstract].":[438],"In:":[439],"Proceedings":[440],"107th":[443],"Annual":[444],"Meeting":[445],"American":[448],"Association":[449],"Cancer":[451,462],"Research;":[452],"2016":[453],"Apr":[454],"16-20;":[455],"New":[456],"Orleans,":[457],"LA.":[458],"Philadelphia":[459],"(PA):":[460],"AACR;":[461],"Res":[463],"2016;76(14":[464],"Suppl):Abstract":[465],"nr":[466],"LB-177.":[467]},"counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1}],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2016-08-23T00:00:00"}